Paperbase

Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics

Sinha, S. Kosalai, K. Arora, S. Namane, A. Sharma, P. Gaikwad, A. N. Brodin, P. Cole, S. T.

Microbiology (Reading, England), 2005

https://doi.org/10.1099/mic.0.27799-0

Sudhir Sinha

Sinha Sudhir

ORCID: 0000-0003-3149-1116

S-Enantiomer of the Antitubercular Compound S006-830 Complements Activity of Frontline TB Drugs and Targets Biogenesis of Mycobacterium tuberculosis Cell Envelope 10.1021/acsomega.7b01281

Correction to “S-Enantiomer of the Antitubercular Compound S006-830 Complements Activity of Frontline TB Drugs and Targets Biogenesis of Mycobacterium tuberculosis Cell Envelope” 10.1021/acsomega.7b01966

Synergy between tuberculin skin test and proliferative T cell responses to PPD or cellmembrane antigens of Mycobacterium tuberculosis for detection of latent TB infection in a high disease-burden setting 10.1371/journal.pone.0204429

Synthesis and anti-tubercular activity of conformationally-constrained and bisquinoline analogs of TMC207 10.1039/c5md00131e

Tetrahydrofuran amino acid-containing gramicidin S analogues with improved biological profiles 10.1039/c5ob00622h

Erratum: Stereoselective total synthesis of Jaspine B (Pachastrissamine) utilizing iodocyclization and an investigation of its cytotoxic activity (Tetrahedron: Asymmetry 24 (2013) (903-908)) 10.1016/j.tetasy.2013.09.013

Semi-quantitative detection of Mycobacterium leprae antigens in skin scrapings: suitability as a laboratory aid for field diagnosis of leprosy 10.1016/j.trstmh.2007.02.026

Caution when standardizing serum antibody competition assays 10.1016/0035-9203(90)90408-7

Stereoselective total synthesis of Jaspine B (Pachastrissamine) utilizing iodocyclization and an investigation of its cytotoxic activity 10.1016/j.tetasy.2013.07.003

C-3 alkyl/arylalkyl-2,3-dideoxy hex-2-enopyranosides as antitubercular agents: Synthesis, biological evaluation, and QSAR study 10.1021/jm070110h

Low molecular weight proteins of outer membrane of Salmonella typhimurium are immunogenic in Salmonella induced reactive arthritis revealed by proteomics 10.1111/j.1365-2249.2007.03362.x

Syntheses of novel antimycobacterial combinatorial libraries of structurally diverse substituted pyrimidines by three-component solid-phase reactions 10.1016/S0960-894X(01)00829-0

Thiophene containing trisubstituted methanes [TRSMs] as identified lead against Mycobacterium tuberculosis 10.1016/j.ejmech.2015.03.036

Additional synthesis on thiophene-containing trisubstituted methanes (TRSMs) as inhibitors of M-tuberculosis and 3D-QSAR studies 10.1080/1062936X.2016.1243575

Naturally produced opsonizing antibodies restrict the survival of Mycobacterium tuberculosis in human macrophages by augmenting phagosome maturation 10.1098/rsob.150171

Application of Huisgen (3 + 2) cycloaddition reaction: Synthesis of 1-(2,3-dihydrobenzofuran-2-yl-methyl [1,2,3]-triazoles and their antitubercular evaluations 10.1016/j.ejmech.2009.09.036

A comparative evaluation of serological assays for lepromatous leprosy 10.5935/0305-7518.19880024

Synthesis, Conformational Studies and Biological Profiles of Tetrahydrofuran Amino-Acid-Containing Cationic Antitubercular Peptides 10.1002/ajoc.201700183

Solid support synthesis of 6-aryl-2-substituted pyrimidin-4-yl phenols as anti-infective agents 10.1016/j.bmcl.2005.08.020

Regioselective synthesis of densely functionalized, enantiopure, sugar-pyrazole hybrids as potential scaffolds for drug discovery 10.1039/c3ra22287j

A major T-cell-inducing cytosolic 23 kDa protein antigen of the vaccine candidate Mycobacterium habana is superoxide dismutase 10.1099/13500872-142-6-1375

Selective reactivity of 2-mercaptoethanol with 5β,6β-epoxide in steroids from Withania somnifera 10.1016/j.steroids.2007.10.006

Search of antitubercular activities in tetrahydroacridines: Synthesis and biological evaluation 10.1016/j.bmcl.2006.07.025

Preparation and reactions of sugar azides with alkynes: synthesis of sugar triazoles as antitubercular agents 10.1016/j.carres.2008.02.013

Synthesis and antitubercular activity of substituted phenylmethyl- and pyridylmethyl amines 10.1016/j.bmc.2006.09.020

An efficient synthesis of aryloxyphenyl cyclopropyl methanones: A new class of anti-mycobacterial agents 10.1016/j.bmcl.2005.07.007

Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis 10.1016/j.bmc.2014.12.060

Immunohistologic comparison between armadillo-derived leprosin and standard lepromin skin tests in leprosy patients 10.1159/000234187

Synthesis of glycosylated β-amino acids as new class of antitubercular agents 10.1016/S0223-5234(02)01398-3

Synthesis, molecular modeling and bio-evaluation of cycloalkyl fused 2-aminopyrimidines as antitubercular and antidiabetic agents 10.1016/j.bmcl.2011.06.040

Synthesis of galactopyranosyl amino alcohols as a new class of antitubercular and antifungal agents 10.1016/j.bmcl.2003.11.020

Substituted hydrazinecarbothioamide as potent antitubercular agents: Synthesis and quantitative structure-activity relationship (QSAR) 10.1016/j.bmcl.2010.02.081

Knowledge based identification of potent antitubercular compounds using structure based virtual screening and structure interaction fingerprints 10.1021/ci8003607

Synthesis and evaluation of antitubercular activity of glycosyl thio- and sulfonyl acetamide derivatives 10.1016/j.bmcl.2008.06.004

Artemisinin-derived stable ozonides: Synthesis and antitubercular activities 10.1007/s00044-006-1504-9

Higher acyclic nitrogen containing deoxy sugar derivatives: A new lead in the generation of antimycobacterial chemotherapeutics 10.1016/S0968-0896(02)00045-7

Effect of substituents on diarylmethanes for antitubercular activity 10.1016/j.ejmech.2006.09.020

A small library of trisubstituted pyrimidines as antimalarial and antitubercular agents 10.1016/j.bmcl.2005.08.053

Novel aryloxy azolyl chalcones with potent activity against Mycobacterium tuberculosis H37Rv 10.1016/j.ejmech.2011.06.037

Anti-tumour activity of a novel coumarin-chalcone hybrid is mediated through intrinsic apoptotic pathway by inducing PUMA and altering Bax/Bcl-2 ratio 10.1007/s10495-014-0975-2

A facile synthesis of α,α′-(EE)-bis(benzylidene)-cycloalkanones and their antitubercular evaluations 10.1016/j.ejmech.2008.09.026

Cassane Diterpenes from Caesalpinia bonduc 10.1016/j.phytochem.2008.12.008

Enhancement of human T cell response to a peptide epitope of 38 kDa antigen of Mycobacterium tuberculosis by liposomes 10.1081/IPH-120003757

Immunoreactive antigens of a candidate leprosy vaccine: Mycobacterium habana 10.5935/0305-7518.19950005

Induction of Th1-type cellular responses in cured/exposed Leishmania-infected patients and hamsters against polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa 10.1016/j.vaccine.2008.06.102

Staurosporine induces apoptosis in human papillomavirus positive oral cancer cells at G2/M phase by disrupting mitochondrial membrane potential and modulation of cell cytoskeleton 10.1016/j.oraloncology.2009.04.009

Antiproliferative action of Xylopia aethiopica fruit extract on human cervical cancer cells 10.1002/ptr.3551

Antigenic definition of plasma membrane proteins of Bacillus Calmette- Guerin: Predominant activation of human T cells by low-molecular-mass integral proteins 10.1046/j.1365-3083.1999.00616.x

Synthesis and in vitro evaluation of novel coumarin-chalcone hybrids as potential anticancer agents 10.1016/j.bmcl.2010.10.116

Picroliv, the iridoid glycoside fraction of Picrorhiza kurroa, selectively augments human T cell response to mycobacterial protein antigens 10.3109/08923979809031518

Synthesis and antitubercular activity of 2-hydroxy-aminoalkyl derivatives of diaryloxy methano phenanthrenes 10.1016/j.bmcl.2005.08.045

Synthesis and antitubercular activities of bis-glycosylated diamino alcohols 10.1016/j.bmc.2005.05.021

Baylis-Hillman reaction: Convenient ascending syntheses and biological evaluation of acyclic deoxy monosaccharides as potential antimycobacterial agents 10.1016/S0968-0896(02)00210-9

Urinary haptoglobin, alpha-1 anti-chymotrypsin and retinol binding protein identified by proteomics as potential biomarkers for lupus nephritis 10.1111/cei.12930

Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics 10.1099/mic.0.27799-0

Proteomic approach for identification and characterization of novel immunostimulatory proteins from soluble antigens of Leishmania donovani promastigotes 10.1002/pmic.200600725

Synthesis and cytotoxicity evaluation of (tetrahydro-β-carboline)-1,3,5-triazine hybrids as anticancer agents 10.1016/j.ejmech.2010.02.001

Solution-phase synthesis of a library of carbapeptide analogues based on glycosylamino acid scaffolds and their in silico screening and antimicrobial evaluation 10.1021/cc800206m

Microparticles induce variable levels of activation in macrophages infected with Mycobacterium tuberculosis 10.1016/j.tube.2010.03.001

Synthesis and anti-tubercular activities of benzo[4,5]furo[2,3-c] chromen - 6-one derivatives 10.2174/2211362611201010006

Discovery of new 1,3,5-triazine scaffolds with potent activityagainst Mycobacterium tuberculosis H37Rv 10.1016/j.ejmech.2010.04.017

Design, synthesis and antitubercular activity of diarylmethylnaphthol derivatives 10.1016/j.bmcl.2007.07.089

Proteome analysis of the plasma membrane of Mycobacterium tuberculosis 10.1002/cfg.211

Urinary osteoprotegerin: A potential biomarker of lupus nephritis disease activity 10.1177/0961203316636470

Stable Tricyclic Antitubercular Ozonides Derived from Artemisinin 10.1021/acs.orglett.5b02296

Synthesis and antimycobacterial activities of glycosylated amino alcohols and amines 10.1016/j.ejmech.2004.12.002

Comparative efficacy of biodegradable liposomes and microspheres as carriers for delivery of Vibrio cholerae antigens in the intestine 10.1016/0264-410X(94)90146-5

Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis 10.1111/j.1365-3083.2008.02171.x

Coupling of proteins to liposomes and their role in understanding delayed type of hypersensitivity in human and mice 10.1007/BF02703891

Melatonin reverses fas, E2F-1 and endoplasmic reticulum stress mediated apoptosis and dysregulation of autophagy induced by the herbicide atrazine in murine splenocytes 10.1371/journal.pone.0108602

Natural product inspired diversity oriented synthesis of tetrahydroquinoline scaffolds as antitubercular agent 10.1021/co100022h

Fractionation of mycobacterial integral membrane proteins by continuous elution SDS-PAGE reveals the immunodominance of low molecular weight subunits for human T cells 10.1046/j.1365-2249.1997.4531351.x

Association of mycobacterial-specific and Mycobacterium leprae specific antibody levels with clinical activity in tuberculoid leprosy: A comparative study of three serological enzyme-immunoassays 10.5935/0305-7518.19910014

Chloropyrimidines as a new class of antimicrobial agents 10.1016/S0968-0896(01)00374-1

Evaluation of Mycobacterium smegmatis as a possible surrogate screen for selecting molecules active against multi-drug resistant Mycobacterium tuberculosis 10.2323/jgam.53.333

A serological test for leprosy based on competitive inhibition of monoclonal antibody binding to the MY2a determinant of Mycobacterium leprae 10.1016/0035-9203(83)90309-7

Cytotoxic clerodane diterpenoids from the leaves of Polyalthia longifolia 10.1080/10236240902765301

Determinants of natural immunity against tuberculosis in an endemic setting: Factors operating at the level of macrophage-Mycobacterium tuberculosis interaction 10.1111/j.1365-2249.2007.03585.x

Synthesis and antitubercular screening of imidazole derivatives 10.1016/j.ejmech.2009.02.013

The detection of subclinical leprosy using a monoclonal antibody based radioimmunoassay 10.5935/0305-7518.19860025

Inhibition of platelet aggregation by rat globin 10.1016/S0049-3848(02)00346-8

Corrigendum to "Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis" [Bioorg. Med. Chem. 23 (2015) 742-752] 10.1016/j.bmc.2015.04.039

Diastereoselective one-pot Wittig olefination-Michael addition and olefin cross metathesis strategy for total synthesis of cytotoxic natural product (+)-varitriol and its higher analogues 10.1039/c1ob06039b

Thiophene containing triarylmethanes as antitubercular agents 10.1016/j.bmcl.2007.10.083

Search of antimycobacterial activities in hybrid molecules with benzopyran skeleton 10.1007/s00044-010-9402-6

Synthesis and optimization of antitubercular activities in a series of 4-(aryloxy)phenyl cyclopropyl methanols 10.1016/j.ejmech.2010.09.063

Synthesis and bio-evaluation of alkylaminoaryl phenyl cyclopropyl methanones as antitubercular and antimalarial agents 10.1016/j.bmc.2010.09.071

Immune responses to Mycobacterium tuberculosis membrane-associated antigens including alpha crystallin can potentially discriminate between latent infection and active tuberculosis disease 10.1371/journal.pone.0228359

Patterns of T and B cell responses to Mycobacterium tuberculosis membrane-associated antigens and their relationship with disease activity in rheumatoid arthritis patients with latent tuberculosis infection 10.1371/journal.pone.0255639

MANTOUX TEST IS INADEQUATE TO DEFINE ALL SUBJECTS WITH LATENT TUBERCULAR INFECTION 10.1136/ANNRHEUMDIS-2018-EULAR.6919

Specificity and function of immunogenic peptides from the 35-kilodalton protein of Mycobacterium leprae 10.1128/IAI.67.3.1501-1504.1999

DETECTION OF MYCOBACTERIAL ANTIGENS IN LEPROSY SERUM IMMUNE-COMPLEX 10.1128/JCM.24.1.169-171.1986

Serological distinction of integral plasma membrane proteins as a class of mycobacterial antigens and their relevance for human T cell activation 10.1111/J.1365-2249.1995.TB03863.X

Synthesis and biological evaluation of 4-thiazolidinone derivatives as potential antimycobacterial agents 10.3998/ARK.5550190.0006.209

Priscille Brodin

Brodin Priscille

ORCID: 0000-0003-0991-7344

Email: priscille.brodin@inserm.fr

How can nanoparticles contribute to antituberculosis therapy? 10.1016/j.drudis.2017.01.011

Host-directed therapies offer novel opportunities for the fight against tuberculosis 10.1016/j.drudis.2017.05.005

A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone 10.3390/toxins9070227

A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone 10.3390/toxins9070227 10.3390/toxins9070227.

Clofazimine encapsulation in nanoporous silica particles for the oral treatment of antibiotic-resistant Mycobacterium tuberculosis infections 10.2217/nnm-2016-0364

Cyclodextrin-based nanocarriers containing a synergic drug combination: a potential formulation for pulmonary administration of antitubercular drugs 10.1016/j.ijpharm.2017.05.030 10.1016/j.ijpharm.2017.05.030.

Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism 10.1007/s00401-016-1652-z

Host-directed therapies offer novel opportunities for the fight against tuberculosis 10.1016/j.drudis.2017.05.005 10.1016/j.drudis.2017.05.005.

Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteria 10.1111/mmi.13535

Impact of pe_ pgrs33 Gene Polymorphisms on Mycobacterium tuberculosis Infection and Pathogenesis 10.3389/fcimb.2017.00137

LppM impact on the colonization of macrophages by Mycobacterium tuberculosis 10.1111/cmi.12619

Phenotypic assays for Mycobacterium tuberculosis infection 10.1002/cyto.a.23129 10.1002/cyto.a.23129.

Reversion of antibiotic resistance in Mycobacterium tuberculosis by spiroisoxazoline SMARt-420 10.1126/science.aag1006

A fragment merging approach towards the development of small molecule inhibitors of Mycobacterium tuberculosis EthR for use as ethionamide boosters 10.1039/c5ob02630j

Khaya grandifoliola C.DC: a potential source of active ingredients against hepatitis C virus in vitro 10.1007/s00705-016-2771-5

Mycobacterium tuberculosis LppM Displays an Original Structure and Domain Composition Linked to a Dual Localization 10.1016/j.str.2016.07.009

Mycolactone The amazing analgesic mycobacterial toxin 10.1051/medsci/20163202007

STAT3 Represses Nitric Oxide Synthesis in Human Macrophages upon Mycobacterium tuberculosis Infection 10.1038/srep29297

2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1 10.1021/cb5007163

Cytosolic Access of Mycobacterium tuberculosis: Critical Impact of Phagosomal Acidification Control and Demonstration of Occurrence In Vivo 10.1371/journal.ppat.1004650

High content screening in chemical biology: overview and main challenges 10.1051/medsci/20153102016

High-Content Screening Technology Combined with a Human Granuloma Model as a New Approach To Evaluate the Activities of Drugs against Mycobacterium tuberculosis 10.1128/aac.03705-14

Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system 10.1016/j.vaccine.2015.03.083

Plant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitro 10.3389/fmicb.2015.00438

Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action 10.1128/jvi.01473-15

Testing chemical and genetic Modulators in Mycobacterium tuberculosis infected cells using phenotypic assays 10.1007/978-1-4939-2450-9_24

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening 10.3791/51114

Ligand Efficiency Driven Design of New Inhibitors of Mycobacterium tuberculosis Transcriptional Repressor EthR Using Fragment Growing, Merging, and Linking Approaches 10.1021/jm500422b

Mycobacterial Toxin Induces Analgesia in Buruli Ulcer by Targeting the Angiotensin Pathways 10.1016/j.cell.2014.04.040

Potent antiviral activity of Solanum rantonnetii and the isolated compounds against hepatitis C virus in vitro 10.1016/j.jff.2014.09.022

A novel specific edge effect correction method for RNA interference screenings 10.1093/bioinformatics/btr648

Discovery of Novel N-Phenylphenoxyacetamide Derivatives as EthR Inhibitors and Ethionamide Boosters by Combining High-Throughput Screening and Synthesis 10.1021/jm3003779

Ethionamide Boosters. 2. Combining Bioisosteric Replacement and Structure-Based Drug Design To Solve Pharmacokinetic Issues in a Series of Potent 1,2,4-Oxadiazole EthR Inhibitors 10.1021/jm200825u

The Balance of Apoptotic and Necrotic Cell Death in Mycobacterium tuberculosis Infected Macrophages Is Not Dependent on Bacterial Virulence 10.1371/journal.pone.0047573

Analogous Mechanisms of Resistance to Benzothiazinones and Dinitrobenzamides in Mycobacterium smegmatis 10.1371/journal.pone.0026675

Ethionamide Boosters: Synthesis, Biological Activity, and Structure-Activity Relationships of a Series of 1,2,4-Oxadiazole EthR Inhibitors 10.1021/jm200076a

High-content screening in infectious diseases 10.1016/j.cbpa.2011.05.023

Functional characterization of the Mycobacterium tuberculosis serine/threonine kinase PknJ 10.1099/mic.0.038133-0

High Content Phenotypic Cell-Based Visual Screen Identifies Mycobacterium tuberculosis Acyltrehalose-Containing Glycolipids Involved in Phagosome Remodeling 10.1371/journal.ppat.1001100

High-content imaging of Mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discovery 10.4155/fmc.10.223

Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting 10.1016/j.biomaterials.2009.09.044

Automated High-Throughput siRNA Transfection in Raw 264.7 Macrophages: A Case Study for Optimization Procedure 10.1177/1087057108328762

Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis 10.1126/science.1171583

High Content Screening Identifies Decaprenyl-Phosphoribose 2 ' Epimerase as a Target for Intracellular Antimycobacterial Inhibitors 10.1371/journal.ppat.1000645

Systematic Genetic Nomenclature for Type VII Secretion Systems 10.1371/journal.ppat.1000507

Control of M-tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP 10.1371/journal.ppat.0040033

Aquatic insects and transmission of Mycobacterium ulcerans 10.1051/medsci/20072367572

ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity 10.1128/jb.00469-07

Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis 10.1371/journal.ppat.0030062

Protection against mycobacterium ulcerans lesion development by exposure to aquatic insect saliva 10.1371/journal.pmed.0040064

Support vector machines for automatic detection of tuberculosis bacteria in confocal microscopy images 10.1109/isbi.2007.356794

Synthesis and antimycobacterial evaluation of benzofurobenzopyran analogues 10.1016/j.bmc.2006.12.009

An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis 10.1128/iai.74.4.2128-2137.2006

Benzofuro 3,2-f 1 benzopyrans: A new class of antitubercular agents 10.1016/j.bmc.2006.03.033

Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence 10.1128/iai.74.1.88-98.2006

High frequency of CD4(+) T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection 10.1128/iai.02086-05

Inactivation of Rv2525c, a substrate of the twin arginine translocation (Tat) system of Mycobacterium tuberculosis, increases beta-lactam susceptibility and virulence 10.1128/jb.00631-06

Evaluation of vaccines in the EU TB vaccine cluster using a guinea pig aerosol infection model of tuberculosis 10.1016/j.tube.2004.09.009

Functional analysis of early secreted antigenic target-6, the dominant T-cell antigen of Mycobacterium tuberculosis, reveals key residues involved in secretion, complex formation, virulence, and immunogenicity 10.1074/jbc.M503515200

Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics 10.1099/mic.0.27799-0

Proteomic identification of M. tuberculosis protein kinase substrates: PknB recruits GarA, a FHA domain-containing protein, through activation loop-mediated interactions 10.1016/j.jmb.2005.05.049

Tuberculosis: from genome to vaccine 10.1586/14760584.4.4.541

Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RDI immunogenicity independently of a 10-kilodalton culture filtrate protein and ESAT-6 10.1128/iai.72.4.2170-2176.2004

Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens 10.1086/421468

ESAT-6 proteins: protective antigens and virulence factors? 10.1016/j.tim.2004.09.007

Macro-array and bioinformatic analyses reveal mycobacterial 'core' genes, variation in the ESAT-6 gene family and new phylogenetic markers for the Mycobacterium tuberculosis complex 10.1099/mic.0.26662-0

CD8(+)-T-cell responses of mycobacterium-infected mice to a newly identified major histocompatibility complex class I-restricted epitope shared by proteins of the ESAT-6 family 10.1128/iai.71.12.7173-7177.2003

Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis 10.1038/nm859

A new evolutionary scenario for the Mycobacterium tuberculosis complex 10.1073/pnas.052548299

Bacterial artificial chromosome-based comparative genomic analysis identifies Mycobacterium microti as a natural ESAT-6 deletion mutant 10.1128/iai.70.10.5568-5578.2002

Disruption of HIV-1 integrase-DNA complexes by short 6-oxocytosine-containing oligonucleotides 10.1021/bi015732y

Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti 10.1046/j.1365-2958.2002.03237.x

6-Oxocytidine containing oligonucleotides inhibit the HIV-1 integrase in vitro 10.1081/ncn-100002322

Determinants of Mg2+-dependent activities of recombinant human immunodeficiency virus type 1 integrase 10.1021/bi000398b

Inhibition of the human immunodeficiency virus type 1 DNA integration by modified oligonucleotides 10.1023/a:1026631910681

Branched oligonucleotide-intercalator conjugate forming a parallel stranded structure inhibits HIV-1 integrase 10.1016/s0014-5793(99)01350-2

Inhibition of HIV-1 integration by mono- & bi-functionalized triple helix forming oligonucleotides 10.1080/07328319908044831

Optimization of alternate-strand triple helix formation at the 5 '-TpA-3 ' and 5 '-ApT-3 ' junctions 10.1093/nar/27.15.3029

A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus 10.1074/jbc.272.25.16010

Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipids 10.1073/pnas.1707840114

ArfGAP1 restricts Mycobacterium tuberculosis entry by controlling the actin cytoskeleton 10.15252/embr.201744371

ArfGAP1 restricts Mycobacterium tuberculosis entry by controlling the actin cytoskeleton 10.15252/embr.201744371 10.15252/embr.201744371.

Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles 10.1038/s41598-017-05453-3

Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosis 10.1038/s41598-017-11843-4 10.1038/s41598-017-11843-4.

Fragment-Sized EthR Inhibitors Exhibit Exceptionally Strong Ethionamide Boosting Effect in Whole-Cell Mycobacterium tuberculosis Assays 10.1021/acschembio.7b00091

Host-pathogen systems for early drug discovery against tuberculosis 10.1016/j.mib.2017.11.017 10.1016/j.mib.2017.11.017.

Legionella pneumophila Modulates Mitochondrial Dynamics to Trigger Metabolic Repurposing of Infected Macrophages 10.1016/j.chom.2017.07.020 10.1016/j.chom.2017.07.020. Epub 2017 Aug 31.

Mycobacterium tuberculosis Controls Phagosomal Acidification by Targeting CISH-Mediated Signaling 10.1016/j.celrep.2017.08.101 10.1016/j.celrep.2017.08.101.

Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipids 10.1073/pnas.1707840114 10.1073/pnas.1707840114.

Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry 10.1128/jvi.01982-17

Multiplexed Quantitation of Intraphagocyte Mycobacterium tuberculosis Secreted Protein Effectors 10.1016/j.celrep.2018.03.125

Oxadiazolone derivatives, new promising multi-target inhibitors against M. tuberculosis 10.1016/j.bioorg.2018.08.025

Proteomics of Mycobacterium infection: Moving towards a Better Understanding of Pathogen-Driven immunomodulation 10.3389/fimmu.2018.00086

Synergy between circular bacteriocin AS-48 and ethambutol against Mycobacterium tuberculosis 10.1128/aac.00359-18

The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase 10.1016/j.tube.2018.08.004

Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosis 10.1038/s41598-017-11843-4

Cyclodextrin-based nanocarriers containing a synergic drug combination: A potential formulation for pulmonary administration of antitubercular drugs 10.1016/j.ijpharm.2017.05.030

Host-pathogen systems for early drug discovery against tuberculosis 10.1016/j.mib.2017.11.017

Legionella pneumophila Modulates Mitochondrial Dynamics to Trigger Metabolic Repurposing of Infected Macrophages 10.1016/j.chom.2017.07.020

Mycobacterium tuberculosis Controls Phagosomal Acidification by Targeting CISH-Mediated Signaling 10.1016/j.celrep.2017.08.101

Phenotypic assays for Mycobacterium tuberculosis infection 10.1002/cyto.a.23129

A fast, fully automated cell segmentation algorithm for high-throughput and high-content screening 10.1002/cyto.a.20627

Compartmentalized Encapsulation of Two Antibiotics in Porous Nanoparticles: an Efficient Strategy to Treat Intracellular Infections 10.1002/ppsc.201800360

Spatiotemporal Changes of the Phagosomal Proteome in Dendritic Cells in Response to LPS Stimulation 10.1074/mcp.RA119.001316

Mycolactone as Analgesic: Subcutaneous Bioavailability Parameters 10.3389/fphar.2019.00378

Intrinsic Antibacterial Activity of Nanoparticles Made of β-Cyclodextrins Potentiates Their Effect as Drug Nanocarriers against Tuberculosis 10.1021/acsnano.8b07902

Mitochondrial Dynamics and Activity in Legionella-Infected Cells 10.1007/978-1-4939-9048-1_13

Heparin-Binding Hemagglutinin Adhesin (HBHA) Is Involved in Intracytosolic Lipid Inclusions Formation in Mycobacteria 10.3389/fmicb.2018.02258

Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from Juncus maritimus, Is a New Inhibitor of Hepatitis C Virus RNA Replication 10.1128/jvi.02009-18

A novel codrug made of the combination of ethionamide and its potentiating booster: synthesis, self-assembly into nanoparticles and antimycobacterial evaluation 10.1039/C9OB00680J

Could Mycolactone Inspire New Potent Analgesics? Perspectives and Pitfalls 10.3390/toxins11090516

Paradoxical Roles of the MAL/Tirap Adaptor in Pathologies. 10.3389/fimmu.2020.569127

Fragment-Based Optimized EthR Inhibitors with in Vivo Ethionamide Boosting Activity. 10.1021/acsinfecdis.9b00277

Intracellular and in vivo evaluation of imidazo[2,1-b]thiazole-5-carboxamide anti-tuberculosis compounds. 10.1371/journal.pone.0227224

Preclinical assessment of a new live attenuated Mycobacterium tuberculosis Beijing-based vaccine for tuberculosis. 10.1016/j.vaccine.2019.11.085

IRG1 controls immunometabolic host response and restricts intracellular Mycobacterium tuberculosis infection 10.1101/761551

Worms' Antimicrobial Peptides. 10.3390/md17090512

T(oo)bAd. 10.1038/s41589-019-0347-x

Theaflavins, polyphenols of black tea, inhibit entry of hepatitis C virus in cell culture. 10.1371/journal.pone.0198226

Plant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitro. 10.3389/fmicb.2015.00488

Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis. 10.1038/nm.3262

Discovery of novel N-phenylphenoxyacetamide derivatives as EthR inhibitors and ethionamide boosters by combining high-throughput screening and synthesis. 10.1021/jm300377g

Shortening the drug discovery pipeline: small molecule high content screening for lead discovery in neglected disease. 10.1186/1753-6561-5-s1-p38

Automated HTS/HCS for antivirals using visual HIV full replication assays. 10.1186/1742-4690-6-s2-p82

Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system. 10.4049/jimmunol.174.6.3570

Cell microbiology interview 10.1111/cmi.13288

Pathogenomic analyses of Mycobacterium microti, an ESX-1-deleted member of the Mycobacterium tuberculosis complex causing disease in various hosts 10.1099/mgen.0.000505

PRABHAKAR KOTA

KOTA PRABHAKAR

ORCID: 0000-0002-7537-8433

Analysis of detection methods for space frequency block code MIMO-OFDM system in fast fading channels 10.15866/irecap.v7i7.13613

Analytical performance of OFDM transceiver on SDR and GNU radio-companion 10.1109/ICCSP.2017.8286471

Fireflies algorithm based optimal scrambling to reduce PAPR in SFBC based MIMO-OFDM 10.15866/irecap.v7i7.13567

Railroad track maintenance device 10.15866/irecap.v7i6.13605

A survey on evolution in information security 10.15866/irecap.v7i6.13347

BER analysis of PAPR reduction techniques in SFBC OFDM system: A review 10.1109/INFOP.2015.7489360

Chronic hyper-leptinemia induces insulin signaling disruption in adipocytes: Implications of NOS2 10.1016/j.freeradbiomed.2017.07.016

Fingerprint and iris biometric controlled smart banking machine embedded with GSM technology for OTP 10.1109/ICACDOT.2016.7877618

Ethyl acetate fraction of Eclipta alba: a potential phytopharmaceutical targeting adipocyte differentiation 10.1016/j.biopha.2017.10.002

Multistage recognition approach for handwritten devanagari script recognition 10.1109/WICT.2012.6409156

C-3 alkyl/arylalkyl-2,3-dideoxy hex-2-enopyranosides as antitubercular agents: Synthesis, biological evaluation, and QSAR study 10.1021/jm070110h

Throughput improvement of high density wireless personal area networks 10.1109/CICN.2014.116

Poliothrysoside and its derivatives as novel insulin sensitizers potentially driving AMPK activation and inhibiting adipogenesis 10.1016/j.ejmech.2014.09.015

Comparison of Different Signal Processing Techniques Used for Extraction of Breathing Frequency of Human Being Hidden Behind a Wall 10.1007/978-981-32-9515-5_1

A withanolide coagulin-L inhibits adipogenesis modulating Wnt/β-catenin pathway and cell cycle in mitotic clonal expansion 10.1016/j.phymed.2013.10.009

Identification and quantification of secondary metabolites of Pterocarpus marsupium by LC–MS techniques and its in-vitro lipid lowering activity 10.1016/j.indcrop.2018.10.047

Ecliptal, a promising natural lead isolated from Eclipta alba modulates adipocyte function and ameliorates metabolic syndrome 10.1016/j.taap.2017.11.016

Restoring thermorheological simplicity in miscible polymer blends: How many hydrogen bonds are required? 10.1021/ma100508c

INTRAVESICAL FEMORAL HEAD 10.1016/S0140-6736(76)92383-7

Facial features based hybrid methods for emotion recognition 10.35940/ijrte.B1065.0982S1019

Temporal immmunometabolic profiling of adipose tissue in HFD-induced obesity: manifestations of mast cells in fibrosis and senescence 10.1038/s41366-018-0228-5

PPP2R5B, a regulatory subunit of PP2A, contributes to adipocyte insulin resistance 10.1016/j.mce.2016.08.016

Review of unstructured architecture for voice and data services in mobile communication 10.1109/ICECCT.2015.7226190

Modeling and throughput analysis of randomly deployed IEEE 802.15.4 based Wireless Personal Area Networks 10.1109/PERVASIVE.2015.7086992

Search of antitubercular activities in tetrahydroacridines: Synthesis and biological evaluation 10.1016/j.bmcl.2006.07.025

A novel CPW-FED circular square-corner fractal antenna with varying notch-band for UWB applications 10.1109/ICCICT.2012.6398126

Preparation and reactions of sugar azides with alkynes: synthesis of sugar triazoles as antitubercular agents 10.1016/j.carres.2008.02.013

Synthesis and antitubercular activity of substituted phenylmethyl- and pyridylmethyl amines 10.1016/j.bmc.2006.09.020

Aegeline inspired synthesis of novel amino alcohol and thiazolidinedione hybrids with antiadipogenic activity in 3T3-L1 cells 10.1016/j.ejmech.2017.11.041

Lipid lowering oxopropanylindole hydrazone derivatives with antioxidant and anti-hyperglycemic activity 10.2174/1568026619666181220112903

Identification of novel PTP1B inhibitors by pharmacophore based virtual screening, scaffold hopping and docking 10.1194/jlr.M039925

Reduced Insulin Receptor Expression Enhances Proximal Tubule Gluconeogenesis 10.1002/jcb.25632

Design and synthesis of novel pyranone-based insulin sensitizers exhibiting in vivo hepatoprotective activity 10.1039/c3md00178d

Recent advancement in nitric oxide research in India 10.16943/ptinsa/2018/49300

Synthesis of galactopyranosyl amino alcohols as a new class of antitubercular and antifungal agents 10.1016/j.bmcl.2003.11.020

Synthesis and evaluation of antitubercular activity of glycosyl thio- and sulfonyl acetamide derivatives 10.1016/j.bmcl.2008.06.004

Artemisinin-derived stable ozonides: Synthesis and antitubercular activities 10.1007/s00044-006-1504-9

Novel indole and triazole based hybrid molecules exhibit potent anti-adipogenic and antidyslipidemic activity by activating Wnt3a/β-catenin pathway 10.1016/j.ejmech.2017.10.034

Effect of substituents on diarylmethanes for antitubercular activity 10.1016/j.ejmech.2006.09.020

Frame converter for cooperative coexistence between IEEE 802.15.4 Wireless Sensor Networks and Wi-Fi 10.1007/978-81-322-2529-4_16

A clerodane diterpene inhibit adipogenesis by cell cycle arrest and ameliorate obesity in C57BL/6 mice 10.1016/j.mce.2014.09.024

Mycobacterium tuberculosis persistence in various adipose depots of infected mice and the effect of anti-tubercular therapy 10.1016/j.micinf.2014.04.006

Chronic hyperinsulinemia reduces insulin sensitivity and metabolic functions of brown adipocyte 10.1530/JOE-16-0099

A facile synthesis of α,α′-(EE)-bis(benzylidene)-cycloalkanones and their antitubercular evaluations 10.1016/j.ejmech.2008.09.026

MiR-876-3p regulates glucose homeostasis and insulin sensitivity by targeting adiponectin 10.1530/JOE-17-0387

Throughput Improvement of Health Care Networks in Retirement Communities 10.1109/ICCTCT.2018.8551157

An approach to remove the clutter and detect the target for ultra-wideband through-wall imaging 10.1088/1742-2132/5/4/005

Extraction of life sign of human being hidden behind the wall 10.1109/ICIINFS.2016.8263071

Development of Unstructured Architecture for Voice and Data Services in Mobile Communication 10.1016/j.procs.2016.07.327

Limb girdle muscular dystrophy (LGMD): Case report 10.7860/JCDR/2015/10107.5486

Chronic hyperinsulinemia promotes meta-inflammation and extracellular matrix deposition in adipose tissue: Implications of nitric oxide 10.1016/j.mce.2018.05.010

Two calorimetric glass transitions in miscible blends containing poly(ethylene oxide) 10.1021/ma702429r

Non verbal approach for emotion detection 10.1007/978-3-319-31277-4_33

Statistical moments based facial expression analysis 10.1109/IADCC.2015.7154768

WPAN based preventive condition monitoring for solar wind energy converters in rural electrification 10.1109/CICN.2013.123

Neural network assisted effective lossy compression of medical images 10.1080/02564602.2006.11657937

Synthesis and antitubercular activities of bis-glycosylated diamino alcohols 10.1016/j.bmc.2005.05.021

Baylis-Hillman reaction: Convenient ascending syntheses and biological evaluation of acyclic deoxy monosaccharides as potential antimycobacterial agents 10.1016/S0968-0896(02)00210-9

Analysis of clutter reduction techniques for through wall imaging in UWB range 10.2528/PIERB09060903

Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics 10.1099/mic.0.27799-0

Saroglitazar reduces obesity and associated inflammatory consequences in murine adipose tissue 10.1016/j.ejphar.2018.01.002

Bile acid receptor agonist GW4064 regulates PPARγ coactivator-1α expression through estrogen receptor-related receptor α 10.1210/me.2010-0512

A self banking biometric machine with fake detection applied to fingerprint and iris along with GSM technology for OTP 10.1109/ICCSP.2016.7754189

Design, synthesis and antitubercular activity of diarylmethylnaphthol derivatives 10.1016/j.bmcl.2007.07.089

Stable Tricyclic Antitubercular Ozonides Derived from Artemisinin 10.1021/acs.orglett.5b02296

Synthesis and antimycobacterial activities of glycosylated amino alcohols and amines 10.1016/j.ejmech.2004.12.002

An iris recognition based on dual tree complex wavelet transform 10.1109/TENCON.2007.4429050

Aegeline inspired synthesis of novel β3-AR agonist improves insulin sensitivity in vitro and in vivo models of insulin resistance 10.1016/j.metabol.2018.03.001

Improvement in detection of human life sign signal hidden behind the wall using clutter reduction technique 10.1109/ETCT.2016.7882972

An automated segmentation method for iris recognition 10.1109/TENCON.2006.344211

Biometric person identification—methods, advances and performance evaluation 10.1080/02564602.2004.11417147

Investigation of Transmission line modelling method for dielectric characterization using ring resonator 10.1109/AEMC.2015.7509157

Role of brown adipose tissue in modulating adipose tissue inflammation and insulin resistance in high-fat diet fed mice 10.1016/j.ejphar.2019.02.044

Adipocyte transdifferentiation and its molecular targets 10.1016/j.diff.2014.07.002

RF and microwave low power dielectric heating using parallel plate applicator to control insect pests on tomato plant 10.2528/PIERM16051806

Recognition of target in through wall imaging using shape feature extraction 10.1109/IGARSS.2011.6049291

Boxed ring resonator for liquid dielectric constant measurement 10.15866/irecap.v8i6.15170

Curcumin-3,4-Dichloro Phenyl Pyrazole (CDPP) overcomes curcumin's low bioavailability, inhibits adipogenesis and ameliorates dyslipidemia by activating reverse cholesterol transport 10.1016/j.metabol.2017.05.005

Determinants of natural immunity against tuberculosis in an endemic setting: Factors operating at the level of macrophage-Mycobacterium tuberculosis interaction 10.1111/j.1365-2249.2007.03585.x

Corrigendum to “Chronic hyper-leptinemia induces insulin signaling disruption in adipocytes: Implications of NOS2.” [Free Radical Biology and Medicine 112 (2017) 93–108](S0891584917306998)(10.1016/j.freeradbiomed.2017.07.016) 10.1016/j.freeradbiomed.2018.05.072

16-Dehydropregnenolone lowers serum cholesterol by up-regulation of CYP7A1 in hyperlipidemic male hamsters 10.1016/j.jsbmb.2017.02.013

Synthesis and antitubercular screening of imidazole derivatives 10.1016/j.ejmech.2009.02.013

Experimental study and analysis of stepped-frequency continuous wave based radar for through the wall detection of life signs 10.1109/TENCON.2016.7848280

Dielectric constant measurement of low loss liquids using stacked multi ring resonator 10.1007/s12046-018-0973-0

Chronic hyperinsulinemia induced miR-27b is linked to adipocyte insulin resistance by targeting insulin receptor 10.1007/s00109-018-1623-z

Simulation modeling and implementation of RF and MW system to control the insect pests in agriculture 10.1109/INDICON.2015.7443504

Application of clutter reduction techniques for detection of metallic and low dielectric target behind the brick wall by stepped frequency continuous wave radar in ultra-wideband range 10.1049/iet-rsn.2010.0059

Pharmacokinetic and metabolism studies of rohitukine in rats by high performance liquid-chromatography with tandem mass spectrometry 10.1016/j.fitote.2014.05.004

Pawan Sharma

Sharma Pawan

ORCID: 0000-0002-2525-5451

Evaluation of anti-leishmanial activity of selected Indian plants known to have antimicrobial properties 10.1007/s00436-009-1554-2

Antibody responses stimulated in rabbits, guinea-pigs and mice by recombinant and synthetic portions of a 75 kDa malarial merozoite protein 10.1016/0264-410X(92)90354-M

Activity of Trifluoperazine against Replicating, Non-Replicating and Drug Resistant M. tuberculosis 10.1371/journal.pone.0044245

Intracellular expression of Mycobacterium tuberculosis-specific 10-kDa antigen down-regulates macrophage B7·1 expression and nitric oxide release 10.1046/j.1365-2249.2003.02258.x

Molecular modelling and comparative structural account of aspartyl β-semialdehyde dehydrogenase of Mycobacterium tuberculosis (H37Rv) 10.1007/s00894-008-0267-2

Early secreted antigen ESAT-6 of mycobacterium tuberculosis promotes protective T helper 17 cell responses in a toll-like receptor-2-dependent manner 10.1371/journal.ppat.1002378

Immunomodulatory action of mycobacterial secretory proteins 10.1016/j.micinf.2003.12.015

Immunogenicity of candidate chimeric DNA vaccine against tuberculosis and leishmaniasis 10.1016/j.vaccine.2009.05.100

Kinesin motor domain of Leishmania donovani as a future vaccine candidate 10.1128/CVI.00433-07

Improved diagnosis of tuberculosis in HIV-positive patients using RD1-encoded antigen CFP-10 10.1016/j.ijid.2008.09.022

Mycobacterium tuberculosis secretory proteins CFP-10, ESAT-6 and the CFP10:ESAT6 complex inhibit lipopolysaccharide-induced NF-κB transactivation by downregulation of reactive oxidative species (ROS) production 10.1038/sj.icb.7100117

Supplementation with RD antigens enhances the protective efficacy of BCG in tuberculous mice 10.1016/j.clim.2007.07.007

Mycobacterium tuberculosis TlyA protein negatively regulates T helper (Th) 1 and Th17 differentiation and promotes tuberculosis pathogenesis 10.1074/jbc.M115.653600

Down-regulation of T helper 1 responses to mycobacterial antigens due to maturation of dendritic cells by 10-kDa Mycobacterium tuberculosis secretory antigen 10.1086/368173

Regulation of immune responses to Mycobacterium tuberculosis secretory antigens by dendritic cells 10.1016/j.tube.2005.08.007

ESAT-6 induced COX-2 expression involves coordinated interplay between PI3K and MAPK signaling 10.1016/j.molimm.2011.11.011

A multivalent combination of experimental antituberculosis DNA vaccines based on Ag85B and regions of difference antigens 10.1016/j.micinf.2006.04.025

Encapsulation of antigenic secretory proteins of mycobacterium tuberculosis in biopolymeric nanoparticles for possible aerosol delivery system 10.1166/jbns.2011.1042

Mycobacterium tuberculosis evades host immunity by recruiting mesenchymal stem cells 10.1073/pnas.1007967107

Expression and characterization of a recombinant kinesin antigen from an old Indian strain (DD8) of Leishmania donovani and comparing it with a commercially available antigen from a newly isolated (KE16) strain of L. donovani 10.1016/j.meegid.2008.02.004

Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics 10.1099/mic.0.27799-0

Identification of a novel role of ESAT-6-dependent miR-155 induction during infection of macrophages with mycobacterium tuberculosis 10.1111/j.1462-5822.2012.01827.x

Cloning, expression, and purification of a novel recombinant antigen from Leishmania donovani 10.1016/j.pep.2005.07.027

Mycobacterium tuberculosis 6 kDa early secreted antigenic target stimulates activation of J774 macrophages 10.1016/j.imlet.2004.11.011

T cells from programmed death-1 deficient mice respond poorly to mycobacterium tuberculosis infection 10.1371/journal.pone.0019864

Pathogen-Specific Treg Cells Expand Early during Mycobacterium tuberculosis Infection but Are Later Eliminated in Response to Interleukin-12 10.1016/j.immuni.2013.06.003

Merozoite surface antigen 2 (MSA-2) gene of Plasmodium falciparum strains from India 10.1016/0166-6851(96)83010-6

Evaluation of the diagnostic potential of region of deletion-1-encoded antigen culture filtrate protein-10 in pulmonary tuberculosis 10.1016/j.diagmicrobio.2007.05.011

Mycobacterium tuberculosis 6-kDa early secreted antigenic target (ESAT-6) protein downregulates Lipopolysaccharide induced c-myc expression by modulating the extracellular signal regulated kinases 1/2 10.1186/1471-2172-8-24

ESAT6 differentially inhibits IFN-γ-inducible class II transactivator isoforms in both a TLR2-dependent and -independent manner 10.1038/icb.2011.54

Co-dominant and reciprocal T-helper cell activity of epitopic sequences and formation of junctional B-cell determinants in synthetic T:B chimeric immunogens 10.1016/0264-410X(93)90102-4

Cross-regulation of CD86 by CD80 differentially regulates T helper responses from Mycobacterium tuberculosis secretory antigen-activated dendritic cell subsets 10.1189/jlb.1003476

Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi region in India 10.1128/AAC.00661-10

Effect of Mycobacterium tuberculosis-specific 10-kilodalton antigen on macrophage release of tumor necrosis factor alpha and nitric oxide 10.1128/IAI.70.12.6558-6566.2002

The PPE18 of Mycobacterium tuberculosis interacts with TLR2 and activates IL-10 induction in macrophage 10.4049/jimmunol.0901367

Immune responses mediating survival of naive BALB/c mice experimentally infected with lethal rodent malaria parasite, Plasmodium yoelii nigeriensis 10.1016/S1286-4579(00)00321-X

Innate immune responses to M. tuberculosis infection 10.1016/j.tube.2011.04.003

Molecular typing of neisseria gonorrhoeae isolates by opa-typing and ribotyping in New Delhi, India 10.1155/2009/934823

Fine specificity of immune responses to epitopic sequences in synthetic peptides containing B and T epitopes from the conserved Plasmodium falciparum blood-stage antigens 10.1016/0264-410X(94)00052-O

Mycobacterium tuberculosis secreted antigen (MTSA-10) modulates macrophage function by redox regulation of phosphatases 10.1111/j.1742-4658.2006.05543.x

Role of M. tuberculosis RD-1 region encoded secretory proteins in protective response and virulence 10.1016/j.tube.2008.05.002

Role of PPE18 Protein in Intracellular Survival and Pathogenicity of Mycobacterium tuberculosis in Mice 10.1371/journal.pone.0052601

Cloning and characterization of aspartate-β-semialdehyde dehydrogenase from Mycobacterium tuberculosis H37 Rv 10.1111/j.1365-2672.2004.02505.x

Expression and purification of the Mycobacterium tuberculosis complex-restricted antigen CFP21 to study its immunoprophylactic potential in mouse model 10.1016/j.pep.2006.03.010

Evaluation of 5 Novel protein biomarkers for the rapid diagnosis of pulmonary and extra-pulmonary tuberculosis: preliminary results 10.1038/srep44121

IL-10 down-regulates the expression of survival associated gene hspX of Mycobacterium tuberculosis in murine macrophage 10.1016/j.bjid.2017.03.009

Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis sensitive and resistant Beijing type from a patient with pulmonary tuberculosis 10.1016/j.ijmyco.2016.10.028

ESAT6 differentially inhibits IFN-γ-inducible class II transactivator isoforms in both a TLR2-dependent and -independent manner. icb201154 [pii] 10.1038/icb.2011.54

Immuno-potentiating role of encapsulated proteins of infectious diseases in biopolymeric nanoparticles as a potential delivery system 10.1166/jbn.2011.1202

Innate immune responses to M. tuberculosis infection. S1472-9792(11)00066-7 [pii] 10.1016/j.tube.2011.04.003

T cells from Programmed Death-1 deficient mice respond poorly to Mycobacterium tuberculosis infection. PONE-D-11-02781 [pii] 10.1371/journal.pone.0019864

Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in India. AAC.00661-10 [pii] 10.1128/AAC.00661-10

Mycobacterium tuberculosis evades host immunity by recruiting mesenchymal stem cells. 1007967107 [pii] 10.1073/pnas.1007967107

Immunogenicity of candidate chimeric DNA vaccine against tuberculosis and leishmaniasis. S0264-410X(09)00837-8 [pii] 10.1016/j.vaccine.2009.05.100

Improved diagnosis of tuberculosis in HIV-positive patients using RD1-encoded antigen CFP-10. S1201-9712(08)01689-5 [pii] 10.1016/j.ijid.2008.09.022

The PPE18 of Mycobacterium tuberculosis interacts with TLR2 and activates IL-10 induction in macrophage. jimmunol.0901367 [pii] 10.4049/jimmunol.0901367

Kinesin motor domain of Leishmania donovani as a future vaccine candidate. CVI.00433-07 [pii] 10.1128/CVI.00433-07

Mycobacterium tuberculosis secretory proteins CFP-10, ESAT-6 and the CFP10:ESAT6 complex inhibit lipopolysaccharide-induced NF-kappaB transactivation by downregulation of reactive oxidative species (ROS) production. 7100117 [pii] 10.1038/sj.icb.7100117

Role of M. tuberculosis RD-1 region encoded secretory proteins in protective response and virulence. S1472-9792(08)00055-3 [pii] 10.1016/j.tube.2008.05.002

Evaluation of the diagnostic potential of region of deletion-1-encoded antigen culture filtrate protein-10 in pulmonary tuberculosis. S0732-8893(07)00234-9 [pii] 10.1016/j.diagmicrobio.2007.05.011

Mycobacterium tuberculosis 6-kDa early secreted antigenic target (ESAT-6) protein downregulates lipopolysaccharide induced c-myc expression by modulating the extracellular signal regulated kinases 1/2. 1471-2172-8-24 [pii] 10.1186/1471-2172-8-24

Supplementation with RD antigens enhances the protective efficacy of BCG in tuberculous mice. S1521-6616(07)01286-7 [pii] 10.1016/j.clim.2007.07.007

A multivalent combination of experimental antituberculosis DNA vaccines based on Ag85B and regions of difference antigens. S1286-4579(06)00235-8 [pii] 10.1016/j.micinf.2006.04.025

Cloning, expression, and purification of a novel recombinant antigen from Leishmania donovani. S1046-5928(05)00261-5 [pii] 10.1016/j.pep.2005.07.027

Expression and purification of the Mycobacterium tuberculosis complex-restricted antigen CFP21 to study its immunoprophylactic potential in mouse model. S1046-5928(06)00094-5 [pii] 10.1016/j.pep.2006.03.010

Mycobacterium tuberculosis secreted antigen (MTSA-10) modulates macrophage function by redox regulation of phosphatases. EJB5543 [pii] 10.1111/j.1742-4658.2006.05543.x

Cloning and characterization of aspartate-beta-semialdehyde dehydrogenase from Mycobacterium tuberculosis H37 Rv. JAM2505 [pii] 10.1111/j.1365-2672.2004.02505.x

Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics. 151/7/2411 [pii] 10.1099/mic.0.27799-0

Mycobacterium tuberculosis 6 kDa early secreted antigenic target stimulates activation of J774 macrophages. S0165-2478(04)00316-5 [pii] 10.1016/j.imlet.2004.11.011

Regulation of immune responses to Mycobacterium tuberculosis secretory antigens by dendritic cells. S1472-9792(05)00068-5 [pii] 10.1016/j.tube.2005.08.007

Cross-regulation of CD86 by CD80 differentially regulates T helper responses from Mycobacterium tuberculosis secretory antigen-activated dendritic cell subsets. jlb.1003476 [pii] 10.1189/jlb.1003476

Immunomodulatory action of mycobacterial secretory proteins. S1286457904000395 [pii] 10.1016/j.micinf.2003.12.015

Down-regulation of T helper 1 responses to mycobacterial antigens due to maturation of dendritic cells by 10-kDa mycobacterium tuberculosis secretory antigen. JID21064 [pii] 10.1086/368173

Intracellular expression of Mycobacterium tuberculosis-specific 10-kDa antigen down-regulates macrophage B7.1 expression and nitric oxide release. 2258 [pii]

Mycobacterium tuberculosis antigens induce the differentiation of dendritic cells from bone marrow. 10.4049/jimmunol.169.12.6856

Immune responses mediating survival of naive BALB/c mice experimentally infected with lethal rodent malaria parasite, Plasmodium yoelii nigeriensis. S1286-4579(00)00321-X [pii]

Fine specificity of immune responses to epitopic sequences in synthetic peptides containing B and T epitopes from the conserved Plasmodium falciparum blood-stage antigens. 0264410X9400052O [pii]

Merozoite surface antigen 2 (MSA-2) gene of Plasmodium falciparum strains from India. 0166685196830106 [pii]

Co-dominant and reciprocal T-helper cell activity of epitopic sequences and formation of junctional B-cell determinants in synthetic T:B chimeric immunogens. 0264-410X(93)90102-4 [pii]

Immunogenicity and efficacy trials in Aotus nancymai monkeys with model compounds representing parts of a 75-kD merozoite surface antigen of Plasmodium falciparum. 10.4269/ajtmh.1992.46.691

Nathalie deboosere

deboosere Nathalie

ORCID: 0000-0002-2873-5485

ArfGAP1 restricts Mycobacterium tuberculosis entry by controlling the actin cytoskeleton. 10.15252/embr.201744371

Mycobacterium tuberculosis Controls Phagosomal Acidification by Targeting CISH-Mediated Signaling. 10.1016/j.celrep.2017.08.101

A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone. 10.3390/toxins9070227

Phenotypic assays for Mycobacterium tuberculosis infection. 10.1002/cyto.a.23129

Fragment-Sized EthR Inhibitors Exhibit Exceptionally Strong Ethionamide Boosting Effect in Whole-Cell Mycobacterium tuberculosis Assays. 10.1021/acschembio.7b00091

STAT3 Represses Nitric Oxide Synthesis in Human Macrophages upon Mycobacterium tuberculosis Infection. 10.1038/srep29297

LppM impact on the colonization of macrophages by Mycobacterium tuberculosis. 10.1111/cmi.12619

A microscopic phenotypic assay for the quantification of intracellular mycobacteria adapted for high-throughput/high-content screening. 10.3791/51114

Adhesion of human pathogenic enteric viruses and surrogate viruses to inert and vegetal food surfaces. 10.1016/j.fm.2012.04.007

Viral elution and concentration method for detection of influenza A viruses in mud by real-time RT-PCR. 10.1016/j.jviromet.2011.10.013

Comparison of chlorine and peroxyacetic-based disinfectant to inactivate Feline calicivirus, Murine norovirus and Hepatitis A virus on lettuce. 10.1016/j.ijfoodmicro.2011.08.011

Direct detection of highly pathogenic avian influenza A/H5N1 virus from mud specimens. 10.1016/j.jviromet.2011.06.002

Development and validation of a concentration method for the detection of influenza a viruses from large volumes of surface water. 10.1128/aem.02484-10

A predictive microbiology approach for thermal inactivation of Hepatitis A virus in acidified berries. 10.1016/j.fm.2010.05.018

Assessment of the removal and inactivation of influenza viruses H5N1 and H1N1 by drinking water treatment. 10.1016/j.watres.2010.01.013

Intra-laboratory validation of a concentration method adapted for the enumeration of infectious F-specific RNA coliphage, enterovirus, and hepatitis A virus from inoculated leaves of salad vegetables. 10.1016/j.ijfoodmicro.2005.11.007

Modelling effect of physical and chemical parameters on heat inactivation kinetics of hepatitis A virus in a fruit model system. 10.1016/j.ijfoodmicro.2003.10.015

Host-pathogen systems for early drug discovery against tuberculosis. 10.1016/j.mib.2017.11.017

Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipids. 10.1073/pnas.1707840114

Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosis. 10.1038/s41598-017-11843-4

Legionella pneumophila Modulates Mitochondrial Dynamics to Trigger Metabolic Repurposing of Infected Macrophages. 10.1016/j.chom.2017.07.020

Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles. 10.1038/s41598-017-05453-3

Host-directed therapies offer novel opportunities for the fight against tuberculosis. 10.1016/j.drudis.2017.05.005

Cyclodextrin-based nanocarriers containing a synergic drug combination: A potential formulation for pulmonary administration of antitubercular drugs. 10.1016/j.ijpharm.2017.05.030

Impact of pe_pgrs33 Gene Polymorphisms on Mycobacterium tuberculosis Infection and Pathogenesis. 10.3389/fcimb.2017.00137

Clofazimine encapsulation in nanoporous silica particles for the oral treatment of antibiotic-resistant Mycobacterium tuberculosis infections. 10.2217/nnm-2016-0364

Reversion of antibiotic resistance in Mycobacterium tuberculosis by spiroisoxazoline SMARt-420. 10.1126/science.aag1006

How can nanoparticles contribute to antituberculosis therapy? 10.1016/j.drudis.2017.01.011

Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism. 10.1007/s00401-016-1652-z

Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteria. 10.1111/mmi.13535

Mycobacterium tuberculosis LppM Displays an Original Structure and Domain Composition Linked to a Dual Localization. 10.1016/j.str.2016.07.009

Khaya grandifoliola C.DC: a potential source of active ingredients against hepatitis C virus in vitro. 10.1007/s00705-016-2771-5

[Mycolactone: the amazing analgesic mycobacterial toxin]. 10.1051/medsci/20163202007

A fragment merging approach towards the development of small molecule inhibitors of Mycobacterium tuberculosis EthR for use as ethionamide boosters. 10.1039/c5ob02630j

Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action. 10.1128/jvi.01473-15

Plant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitro. 10.3389/fmicb.2015.00488

Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system. 10.1016/j.vaccine.2015.03.083

Cytosolic access of Mycobacterium tuberculosis: critical impact of phagosomal acidification control and demonstration of occurrence in vivo. 10.1371/journal.ppat.1004650

[High content screening in chemical biology: overview and main challenges]. 10.1051/medsci/20153102016

Testing chemical and genetic Modulators in Mycobacterium tuberculosis infected cells using phenotypic assays. 10.1007/978-1-4939-2450-9_24

2-Carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1. 10.1021/cb5007163

High-content screening technology combined with a human granuloma model as a new approach to evaluate the activities of drugs against Mycobacterium tuberculosis. 10.1128/aac.03705-14

Mycobacterial toxin induces analgesia in buruli ulcer by targeting the angiotensin pathways. 10.1016/j.cell.2014.04.040

Ligand efficiency driven design of new inhibitors of Mycobacterium tuberculosis transcriptional repressor EthR using fragment growing, merging, and linking approaches. 10.1021/jm500422b

Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis. 10.1038/nm.3262

The balance of apoptotic and necrotic cell death in Mycobacterium tuberculosis infected macrophages is not dependent on bacterial virulence. 10.1371/journal.pone.0047573

Discovery of novel N-phenylphenoxyacetamide derivatives as EthR inhibitors and ethionamide boosters by combining high-throughput screening and synthesis. 10.1021/jm300377g

Ethionamide boosters. 2. Combining bioisosteric replacement and structure-based drug design to solve pharmacokinetic issues in a series of potent 1,2,4-oxadiazole EthR inhibitors. 10.1021/jm200825u

A novel specific edge effect correction method for RNA interference screenings. 10.1093/bioinformatics/btr648

Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis. 10.1371/journal.pone.0026675

High-content screening in infectious diseases. 10.1016/j.cbpa.2011.05.023

Ethionamide boosters: synthesis, biological activity, and structure-activity relationships of a series of 1,2,4-oxadiazole EthR inhibitors. 10.1021/jm200076a

Shortening the drug discovery pipeline: small molecule high content screening for lead discovery in neglected disease. 10.1186/1753-6561-5-s1-p38

High content phenotypic cell-based visual screen identifies Mycobacterium tuberculosis acyltrehalose-containing glycolipids involved in phagosome remodeling. 10.1371/journal.ppat.1001100

High-content imaging of Mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discovery. 10.4155/fmc.10.223

Functional characterization of the Mycobacterium tuberculosis serine/threonine kinase PknJ. 10.1099/mic.0.038133-0

High content screening identifies decaprenyl-phosphoribose 2' epimerase as a target for intracellular antimycobacterial inhibitors. 10.1371/journal.ppat.1000645

Systematic genetic nomenclature for type VII secretion systems. 10.1371/journal.ppat.1000507

Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting. 10.1016/j.biomaterials.2009.09.044

Automated HTS/HCS for antivirals using visual HIV full replication assays. 10.1186/1742-4690-6-s2-p82

Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis. 10.1126/science.1171583

Automated high-throughput siRNA transfection in raw 264.7 macrophages: a case study for optimization procedure. 10.1177/1087057108328762

Control of M. tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP. 10.1371/journal.ppat.0040033

ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity. 10.1128/jb.00469-07

[Aquatic insects and transmission of Mycobacterium ulcerans]. 10.1051/medsci/20072367572

Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis. 10.1371/journal.ppat.0030062

Protection against Mycobacterium ulcerans lesion development by exposure to aquatic insect saliva. 10.1371/journal.pmed.0040064

Synthesis and antimycobacterial evaluation of benzofurobenzopyran analogues. 10.1016/j.bmc.2006.12.009

Inactivation of Rv2525c, a substrate of the twin arginine translocation (Tat) system of Mycobacterium tuberculosis, increases beta-lactam susceptibility and virulence. 10.1128/jb.00631-06

High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection. 10.1128/iai.02086-05

Benzofuro[3,2-f][1]benzopyrans: a new class of antitubercular agents. 10.1016/j.bmc.2006.03.033

An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis. 10.1128/iai.74.4.2128-2137.2006

Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence. 10.1128/iai.74.1.88-98.2006

Tuberculosis: from genome to vaccine. 10.1586/14760584.4.4.541

Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics. 10.1099/mic.0.27799-0

Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system. 10.4049/jimmunol.174.6.3570

Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis. 10.1016/j.tube.2004.09.009

ESAT-6 proteins: protective antigens and virulence factors? 10.1016/j.tim.2004.09.007

Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens. 10.1086/421468

Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RD1 immunogenicity independently of a 10-kilodalton culture filtrate protein and ESAT-6. 10.1128/iai.72.4.2170-2176.2004

CD8+-T-cell responses of Mycobacterium-infected mice to a newly identified major histocompatibility complex class I-restricted epitope shared by proteins of the ESAT-6 family. 10.1128/iai.71.12.7173-7177.2003

Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. 10.1038/nm859

Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. 10.1046/j.1365-2958.2002.03237.x

Bacterial artificial chromosome-based comparative genomic analysis identifies Mycobacterium microti as a natural ESAT-6 deletion mutant. 10.1128/iai.70.10.5568-5578.2002

Disruption of HIV-1 integrase-DNA complexes by short 6-oxocytosine-containing oligonucleotides. 10.1021/bi015732y

IRG1 controls immunometabolic host response and restricts intracellular Mycobacterium tuberculosis infection 10.1101/761551

Large scale screening discovers clofoctol as an inhibitor of SARS-CoV-2 replication that reduces COVID-19-like pathology 10.1101/2021.06.30.450483

abdelkader Namane

Namane abdelkader

ORCID: 0000-0001-7180-7619

A minimal bacterial RNase J-based degradosome is associated with translating ribosomes 10.1093/nar/gks945

New Markers in Anopheles gambiae Salivary Glands After Plasmodium berghei Infection 10.1089/vbz.2012.0964

Yeast ribosomal protein L7 and its homologue Rlp7 are simultaneously present at distinct sites on pre-60S ribosomal particles 10.1093/nar/gkt726

Identification of Outer Membrane Proteins Altered in Response to UVC-Radiation in Vibrio parahaemolyticus and Vibrio alginolyticus 10.1007/s12088-012-0299-2

A Critical Role of Perinuclear Filamentous Actin in Spatial Repositioning and Mutually Exclusive Expression of Virulence Genes in Malaria Parasites 10.1016/j.chom.2011.09.013

Characterization of the Antibody Response to the Saliva of Phlebotomus papatasi in People Living in Endemic Areas of Cutaneous Leishmaniasis 10.4269/ajtmh.2011.10-0598

AIF promotes chromatinolysis and caspase-independent programmed necrosis by interacting with histone H2AX 10.1038/emboj.2010.43

CCSV-MPase, a Novel Procoagulant Metalloproteinase from Cerastes cerastes Venom: Purification, Biochemical Characterization and Protein Identification 10.1007/s10930-010-9273-1

Identification of Leishmania-specific protein phosphorylation sites by LC-ESI-MS/MS and comparative genomics analyses 10.1002/pmic.201000305

Identification of outer membrane proteins of Vibrio parahaemolyticus and Vibrio alginolyticus altered in response to gamma-irradiation or long-term starvation 10.1016/j.resmic.2010.10.009

Phosphoproteome dynamics reveal heat-shock protein complexes specific to the Leishmania donovani infectious stage 10.1073/pnas.0914768107

IgG Autoantibody to Brain Beta Tubulin III Associated with Cytokine Cluster-II Discriminate Cerebral Malaria in Central India 10.1371/journal.pone.0008245

60S ribosomal subunit assembly dynamics defined by semi-quantitative mass spectrometry of purified complexes 10.1093/nar/gkn469

Comprehensive proteome analysis of Mycobacterium ulcerans and quantitative comparison of mycolactone biosynthesis 10.1002/pmic.200701018

In Vivo Interactome of Helicobacter pylori Urease Revealed by Tandem Affinity Purification 10.1074/mcp.M800160-MCP200

Phosphoproteornic analysis of Leishmania donovani pro- and amastigote stages 10.1002/pmic.200700697

A critical role for peptidoglycan N-deacetylation in Listeria evasion from the host innate immune system 10.1073/pnas.0609672104

Self-Reactivities to the Non-Erythroid Alpha Spectrin Correlate with Cerebral Malaria in Gabonese Children 10.1371/journal.pone.0000389

The HcaR regulatory protein of Photorhabdus luminescens affects the production of proteins involved in oxidative stress and toxemia 10.1002/pmic.200700609

The p21-activated protein kinase inhibitor Skb15 and its budding yeast homologue are 60S ribosome assembly factors 10.1128/MCB.00064-07

The Pseudomonas aeruginosa LasB metalloproteinase regulates the human urokinase-type plasminogen activator receptor through domain-specific endoproteolysis 10.1128/IAI.00015-07

The salivary glands and saliva of Anopheles gambiae as an essential step in the Plasmodium life cycle: A global proteomic study 10.1002/pmic.200700334

Yeast homolog of a cancer-testis antigen defines a new transcription complex 10.1038/sj.emboj.7601235

Cryptic Pol II transcripts are degraded by a nuclear quality control pathway involving a new poly(A) polymerase 10.1016/j.cell.2005.04.030

Deletion of EFL1 results in heterogeneity of the 60 S GTPase-associated rRNA conformation 10.1016/j.jmb.2005.07.037

Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics 10.1099/mic.0.27799-0

LANCL1, an erythrocyte protein recruited to the Maurer's clefts during Plasmodium falciparum development 10.1016/j.molbiopara.2005.01.013

Limited efficiency of prolyl-endopeptidase in the detoxification of gliadin peptides in celiac disease 10.1053/j.gastro.2005.06.016

Sequential neural network combination for degraded machine printed character recognition 10.1117/12.587162

Staphylococcus aureus RNAIII and the endoribonuclease III coordinately regulate spa gene expression 10.1038/sj.emboj.7600572

AstR-AstS, a new two-component signal transduction system, mediates swarming, adaptation to stationary phase and phenotypic variation in Photorhabdus luminescens 10.1099/mic.0.26563-0

Global analysis of gene expression in an rpoN mutant of Listeria monocytogenes 10.1099/mic.0.26860-0

Plasmin cleaves the juxtamembrane domain and releases truncated species of the urokinase receptor (CD87) from human bronchial epithelial cells 10.1016/j.febslet.2004.08.009

Alterations of the intestinal transport and processing of gliadin peptides in celiac disease 10.1016/S0016-5085(03)01049-7

Correlation between alterations of the penicillin-binding protein 2 and modifications of the peptidoglycan structure in Neisseria meningitidis with reduced susceptibility to penicillin G 10.1074/jbc.M304607200

Detailed structural analysis of the peptidoglycan of the human pathogen Neisseria meningitidis 10.1074/jbc.M304749200

Sequential protein association with nascent 60S ribosomal particles 10.1128/MCB.23.13.4449-4460.2003

A proteomic analysis of the salt stress response of Listeria monocytogenes 10.1016/S0378-1097(02)00938-2

A proteomic study of Escherichia coli O157 : H7 NCTC 12900 cultivated in biofilm or in planktonic growth mode 10.1016/S0378-1097(02)00879-0

Comparison of protein patterns of Listeria monocytogenes grown in biofilm or in planktonic mode by proteomic analysis 10.1016/S0378-1097(02)00571-2

Proteome analysis of the plasma membrane of Mycobacterium tuberculosis 10.1002/cfg.211

Structural and nucleotide-binding properties of YajQ and YnaF, two Escherichia coli proteins of unknown function 10.1110/ps.0217502

A yeast homolog of chromatin assembly factor 1 is involved in early ribosome assembly 10.1016/S0960-9822(01)00584-X

Identification of 12 new yeast mitochondrial ribosomal proteins including 6 that have no prokaryotic homologues 10.1074/jbc.M010864200

Nog2p, a putative GTPase associated with pre-60S subunits and required for late 60S maturation steps 10.1093/emboj/20.22.6475

Nonspecific B and T cell-stimulatory activity mediated by mast cells is associated with exosomes 10.1159/000053691

Genetic and biochemical characterization of Salmonella enterica serovar Typhi deoxyribokinase 10.1128/JB.182.4.869-873.2000

Assay of nucleoside 2-deoxyribosyltransferase activity with pyruvate kinase lactate dehydrogenase coupling system 10.1006/abio.1999.4136

Decreased capacity of recombinant 45/47-kDa molecules (Apa) of Mycobacterium tuberculosis to stimulate T lymphocyte responses related to changes in their mannosylation pattern 10.1074/jbc.274.45.32023

Unusual nucleotide conformations in GNRA and UNCG type tetraloop hairpins: evidence from Raman markers assignments 10.1093/nar/27.5.1398

Structural features of the UCCG and UGCG tetraloops in very short hairpins as evidenced by optical spectroscopy 10.1021/bi980011t

Prochlorothrix hollandica PCC 9006: Genomic properties of an axenic representative of the chlorophyll a/b-containing oxyphotobacteria 10.1016/S0923-2508(97)81590-2

UNCG tetraloops in short oligoribonucleotides reveal high thermodynamic stability and unusual structural properties in aqueous phase as confirmed by optical and NMR spectroscopies 10.1016/S0022-2860(96)09536-1

Conformational studies by H-1 NMR of the HIV enhancer: The transcription factors NF-kappa B and Sp1 binding domains 10.1002/(SICI)1097-458X(199612)34:133.0.CO;2-F

Potential lipophilic nucleotide prodrugs: Synthesis, hydrolysis, and antiretroviral activity of AZT and d4T acyl nucleotides 10.1021/jo951354p

Synthesis of acylphosphates of purine ribonucleosides 10.1016/S0040-4039(96)02016-3

Chemienzymatic synthesis of uridine nucleotides labeled with [N-15] and [C-13] 10.1006/abio.1995.0007

SYNTHESIS OF ACYL PYROPHOSPHATES - APPLICATION TO THE SYNTHESIS OF NUCLEOTIDE LIPOPHILIC PRODRUGS 10.1016/0040-4039(94)02322-3

SYNTHESIS OF NUCLEOTIDE LIPOPHILIC PRODRUGS CONTAINING 2 INHIBITORS TARGETED AGAINST DIFFERENT PHASES OF THE HIV REPLICATION CYCLE 10.1080/15257779508012471

ENZYMATIC-SYNTHESIS OF DISACCHARIDE-SERINE AND PEPTIDE CONJUGATES 10.1016/S0960-894X(01)80708-3

ENZYMATIC-SYNTHESIS OF SOME O-BETA-D-DIGALACTOSYL GLYCOPEPTIDES, USING BETA-D-GALACTOSIDASE 10.1016/0008-6215(93)84137-U

INFLUENCE OF GLUCOSE ON THE DEOXYGLUCOSE METABOLISM IN SACCHAROMYCES-CEREVISIAE - DETECTION AND IDENTIFICATION OF DEOXYGLUCOSE AND TREHALOSE DERIVATIVES BY H-1-NMR AND C-13-NMR SPECTROSCOPY 10.1016/0300-9084(93)90134-E

BIOCHROMATOGRAPHY AND MOLECULAR-BIOLOGY - A REPORT ON THE 4TH EUROPEAN MEETING OF GFBC - BIOCHROMATOGRAPHY AND MOLECULAR-BIOLOGY, LA-GRANDE-MOTTE, FRANCE, 12-14 MAY, 1992 10.1016/0165-9936(92)87084-W

IMPROVED BRAIN DELIVERY OF AZT USING A GLYCOSYL PHOSPHOTRIESTER PRODRUG 10.1021/jm00094a018

H-1-NMR AND P-31-NMR STUDIES OF DITERCALINIUM BINDING TO A D(GCGC)2 AND D(CCTATAGG)2 MINIHELICES - A SEQUENCE SPECIFICITY STUDY 10.1002/bip.360310307

NEW FLUORESCENT AND PHOTOACTIVABLE ANALOGS ACTING ON NUCLEOTIDE BINDING ENZYMES 10.1016/S0040-4039(00)92285-8

SYNTHESIS OF FLUORESCEINYLATED 2'-DEOXYADENOSINE - MONOPHOSPHATE, DIPHOSPHATE AND TRIPHOSPHATE DERIVATIVES 10.1016/0040-4039(90)80130-E

SYNTHESIS OF TETRATHYMIDYLATES COVALENTLY LINKED TO ELLIPTICINE DERIVATIVES 10.1080/07328319008045105

SIMPLE CHEMICAL SYNTHESIS AND HYBRIDIZATION PROPERTIES OF NON-RADIOACTIVE DNA PROBES 10.1016/0300-9084(89)90003-5

SYNTHESIS OF FLUORESCENT OR BIOTINYLATED NUCLEOSIDE COMPOUNDS 10.1016/S0040-4020(01)81640-9

STRUCTURAL ANALOGS OF SEROTONIN AS AFFINITY MARKERS OF SEROTONINERGIC RECEPTORS 10.1016/S0040-4039(00)88925-X

Differential expression of Ixodes ricinus salivary gland proteins in the presence of the Borrelia burgdorferi sensu lato complex 10.1016/j.jprot.2013.10.033

Isolation, Functional Characterization and Proteomic Identification of CC2-PLA(2) from Cerastes cerastes Venom: A Basic Platelet-Aggregation-Inhibiting Factor 10.1007/s10930-013-9534-x

Proteomic Analysis of Intact Flagella of Procyclic Trypanosoma brucei Cells Identifies Novel Flagellar Proteins with Unique Sub-localization and Dynamics 10.1074/mcp.M113.033357

Cdc48-associated complex bound to 60S particles is required for the clearance of aberrant translation products 10.1073/pnas.1221724110

Rqc1 and Ltn1 Prevent C-terminal Alanine-Threonine Tail (CAT-tail)-induced Protein Aggregation by Efficient Recruitment of Cdc48 on Stalled 60S Subunits. 10.1074/jbc.M116.722264

Role of the N-Acetylmuramoyl-l-Alanyl Amidase, AmiA, of Helicobacter pylori in Peptidoglycan Metabolism, Daughter Cell Separation, and Virulence. 10.1089/mdr.2016.0070

The ribosome-bound quality control complex remains associated to aberrant peptides during their proteasomal targeting and interacts with Tom1 to limit protein aggregation 10.1091/mbc.E16-10-0746

Actin activates Pseudomonas aeruginosa ExoY nucleotidyl cyclase toxin and ExoY-like effector domains from MARTX toxins 10.1038/ncomms13582

The cryo-EM structure of a ribosome-Ski2-Ski3-Ski8 helicase complex 10.1126/science.aaf7520

Infection by chikungunya virus modulates the expression of several proteins in Aedes aegypti salivary glands 10.1186/1756-3305-5-264

A SKI subcomplex specifically required for the degradation of ribosome-free RNA regions 10.1101/409490

Detection and Degradation of Nonsense-mediated mRNA Decay Substrates Involve Two Distinct Upf1-bound Complexes 10.1101/266833

Nonsense‐mediated mRNA decay involves two distinct Upf1‐bound complexes 10.15252/embj.201899278

A specialised SKI complex assists the cytoplasmic RNA exosome in the absence of direct association with ribosomes 10.15252/embj.2018100640

Structural and functional insights into CWC27/CWC22 heterodimer linking the exon junction complex to spliceosomes. 10.1093/nar/gkaa267

Structural inventory of native ribosomal ABCE1-43S pre-initiation complexes 10.1101/2020.07.09.194902

A structural inventory of native ribosomal ABCE1‐43S pre‐initiation complexes 10.15252/embj.2020105179